Barr Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., and Cephalon, Inc. | Attorney General - State of Colorado

Barr Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., and Cephalon, Inc.

The States of Alabama, Alaska, Arizona, Arkansas, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming v. Barr Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., and Cephalon, Inc.

Press Releases:
11/17/2016
06/06/2017

The settlement included $35 million to compensate eligible consumers who may have been harmed by the alleged conduct. 

Originally, the deadline for consumers to file claims or object to the settlement was Thursday, April 13, 2017.  At the State’s request, the Court granted an extension of the time to file a claim or object to the settlement.  The new deadline is June 25, 2017.

For more information or to obtain a claim form, visit www.StateAGProvigilSettlement.com or call 1-877-236-1413.